Interferons-α and -γ in clinical veterinary practice in the prevention and treatment of infectious diseases in cattle and pigs (review)

The review article analyzes the existing world experience in the use of interferons IFN-α and -γ as well as drugs based on them in clinical veterinary practice in cattle and pigs. The selection of literary sources was carried out on the basis of their relevance and the depth of the research (search retrospectiveness is 30 years). It has been established that IFNs are widely used in the prevention and treatment of both infectious and non-infectious diseases, which can be divided into 3 groups: viral infections, oncological diseases, bacterial and aseptic diseases. The use of IFNs is due to their antiviral activity and immunoregulatory effect. Thus, IFN-α exhibits antiviral activity and is the first line of nonspecific immune defense, an inducer of IFN-γ synthesis and the main coordinator of the body's successful response to a viral infection. At the same time, IFN-γ provides immunoregulatory, anti-inflammatory and mediated antibacterial action by stimulating the production of macrophages and participating in the differentiation of lymphocytes. Clinical efficacy is expressed in a decrease or cessation of the infectious process, a decrease in leukocytosis and neutrophilia, relief of acidotic syndrome, an increase in the body weight of animals and an improvement in the general clinical condition. Currently, IFN therapy is one of the most promising and constantly expanding areas of immunopharmacology and treatment of common respiratory, gastrointestinal, obstetric-gynecological diseases in farm animals.

1. Chevaliez S., Pawlotsky J. M. Interferons and their use in persistent viral infections. Handb Exp Pharmacol. 2009;189:203-241. DOI: https://doi.org/10.1007/978-3-540-79086-0_8

2. George P. M., Badiger R., Alazawi W., Foster G. R., Mitchell J. A. Pharmacology and therapeutic potential of interferons. Pharmacol Ther. 2012;135(1):44-53. DOI: https://doi.org/10.1016/j.pharmthera.2012.03.006

3. Denisov L. A., Sholokhov I. V. Otkrytie interferona i ego klinicheskoe primenenie. [Interferon discovery and its clinical experience]. Infektsionnye bolezni: novosti, mneniya, obuchenie = Infectious diseases. News, Opinions, Training. 2017;(1):23-31. (In Russ.). URL: https://cyberleninka.ru/article/n/otkrytie-interferona-i-ego-klinicheskoe-primenenie

4. Valiev T. T. Klinicheskoe primenenie interferonov: sovremennyy vzglyad na voprosy effektivnosti i bezopasnosti. Obzor literatury. [Interferon clinical use: modern view on efficacy and safety. Literature review]. Pediatriya. Consilium Medicum = Pediatrics. Consilium Medicum. 2020;(3):95-104. (In Russ.). URL: https://www.elibrary.ru/item.asp?id=44155087

5. Vasilevsky I. V., Lavrienko A. V. Kliniko-farmakologicheskoe obosnovanie primeneniya interferonov v klinicheskoy praktike. [Clinico-pharmacological rationale for using interferons in clinical practice]. Zdravookhranenie = Healthcare. 2016;(7):51-63. (In Belarus). URL: https://www.elibrary.ru/item.asp?id=28825240

6. Aylamazyan E. K., Pavlov I. P. Immunokorrigiruyushchaya terapiya infektsionno-vospalitel'nykh zabolevaniy zhenskoy polovoy sfery. [Immunocorrective therapy of infectious and inflammatory diseases of the female genital area]. Saint-Petersburg: Taktik-Studio, 2007. 56 p. URL: https://medi.ru/info/1673/

7. Ershov F. I. Otkrytie biologicheskogo fenomena i ego posle-duyushchee nauchnoe poznanie. [Discovery and scientific investigation of a biological phenomenon]. Voprosy virusologii = Problems of Virology. 2012;57(4):4-8. (In Russ.). URL: https://www.elibrary.ru/item.asp?id=18750403

8. Vavilenkova Yu. A. Sovremennye predstavleniya o sisteme interferona. [Modern conception of interferon system]. Vestnik Smolenskoy gosudarstvennoy meditsinskoy akademii = Vestnik of Smolensk State Medical Academy. 2012;11(2):74-82. (In Russ.). URL: https://cyberleninka.ru/article/n/sovremennye-predstavleniya-o-sisteme-interferona

9. Kak G., Raza M., Tiwari B. K. Interferon-gamma (IFN-γ): Exploring its implications in infectious diseases. Biomol Concepts. 2018;9(1):64-79. DOI: https://doi.org/10.1515/bmc-2018-0007

10. Ershov F. I., Narovlyansky A. N. Teoreticheskie i prikladnye aspekty sistemy interferonov: k 60-letiyu otkrytiya interferonov. [Theoretical and applied aspects of the interferon system: to the 60th anniversary of the discovery of interferons]. Voprosy virusologii = Problems of Virology. 2018;63(1):10-18. (In Russ.). DOI: http://doi.org/10.18821/0507-4088-2018-63-1-10-18

11. Friesen H. J., Stein S., Evinger M., Familletti P. C., Moschera J., Meienhofer J., Shively J., Pestka S. Purification and molecular characterization of human fibroblast interferon. Archives of biochemistry and biophysics. 1981;206(2):432-450. DOI: https://doi.org/10.1016/0003-9861(81)90111-9

12. Rubinstein M., Rubinstein S., Familetty P. C., Gross M. S., Miller R. S., Waldman A. A., Pestka S. Human leukocyte interferon purified to homogeneity. Science. 1978;202(4374):1289-1290. DOI: https://doi.org/10.1126/science.725605

13. Lidzhieva A. A., Smolyarchuk E. A., Kokorina A. E., Smirnov V. V., Egorenkov E. A. Ispol'zovaniya biotekhnologicheskikh preparatov kak sposob povysheniya bezopasnosti farmakoterapii: sovremennoe sostoyanie problemy i perspektivy razvitiya. [Biotechnological preparations as a means of improving the safety of pharmacotherapy: state of the art and prospects of development]. BIOpreparaty. Profilaktika, diagnostika, lechenie = BIOpreparations. Prevention, Diagnosis, Treatment. 2016;16(3):145-150. (In Russ.). URL: https://www.elibrary.ru/item.asp?id=26619560

14. Negishi H., Taniguchi T., Yanai H. The Interferon (IFN) Class of Cytokines and the IFN Regulatory Factor (IRF) Transcription Factor Family. Cold Spring Harb Perspect Biol. 2018;10(11):a028423. DOI: https://doi.org/10.1101/cshperspect.a028423

15. Li S. F., Gong M. J., Zhao F. R., Shao J. J., Xie Y. L., Zhang Y. G., Chang H. Y. Type I Interferons: Distinct Biological Activities and Current Applications for Viral Infection. Cell Physiol Biochem. 2018;51(5):2377-2396. DOI: https://doi.org/10.1159/000495897

16. Lazear H. M., Schoggins J. W., Diamond M. S. Shared and Distinct Functions of Type I and Type III Interferons. Immunity. 2019;50(4):907-923. DOI: https://doi.org/10.1016/j.immuni.2019.03.025

17. Prokulevich V. A., Potapovich M. I. Veterinarnye preparaty na osnove interferona. [Veterinary drugs based on interferon]. Vestnik BGU. Seriya 2: Khimiya. Biologiya. Geografiya. 2011;(3):51-55. (In Belarus). URL: https://www.elibrary.ru/item.asp?id=21699862

18. Kozlova O. A., Medvedeva G. F. Effektivnost' primeneniya biopreparata «Biferon-B» korovam v period zapuska. Prodolzhitel'nost' stel'nosti, tyazhest' otela, zabolevaemost' telyat. [The effectiveness of the use of the biological product "Biferon-B" to cows during the cow drying-off period. Duration of gestation, severity of calving, morbidity of calves]. Aktual'nye problemy intensivnogo razvitiya zhivotnovodstva. 2020;(23-2):156-161. (In Belarus). URL: https://www.elibrary.ru/item.asp?id=43355827

19. Mazina N. K., Mazin P. V., Redkina D. V. Vliyanie tsikloferona na effektivnost' farmakoterapii infektsionnykh zabolevaniy shirokogo spektra u detey i vzroslykh. [The influence of cycloferone on the effectiveness of pharmacotherapy of wide spectrum of infectious diseases in children and adults: systematic review and meta-analysis]. Antibiotiki i khimioterapiya = Antibiotics and Chemotherapy. 2018;63(11-12):31-40. (In Russ.). URL: https://www.elibrary.ru/item.asp?id=38236173

20. Narovlyansky A. N., Ershov F. I., Gintsburg A. L. Interferony: perspektivnye napravleniya issledovaniy. [Interferons: perspective directions of research]. Immunologiya = Immunologiya. 2013;34(3):168-172. (In Russ.). URL: https://www.elibrary.ru/item.asp?id=19528083

21. Sun S., Zhang X., Tough D., Sprent J. Multiple effects of immunostimulatory DNA on T cells and the role of type I interferons. Springer Semin Immunopathol. 2000;22(1-2):77-84. DOI: https://doi.org/10.1007/s002810000028

22. Mehrotra A., D'Angelo J. A., Romney-Vanterpool A., Chu T., Bertoletti A., Janssen H. L. A., Gehring A. J. IFN-α Suppresses Myeloid Cytokine Production, Impairing IL-12 Production and the Ability to Support T-Cell Proliferation. J Infect Dis. 2020;222(1):148-157. DOI: https://doi.org/10.1093/infdis/jiaa064

23. Samuel C. E. Antiviral actions of interferons. Clinical microbiology reviews. 2001;14(4):778-809. DOI: https://doi.org/10.1128/CMR.14.4.778-809.2001

24. Italiani P., Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Frontiers in Immunology. 2014;5:514. DOI: https://doi.org/10.3389/fimmu.2014.00514

25. Martinez F. O., Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Reports. 2014;6:13. DOI: https://doi.org/10.12703/P6-13

26. Gamaley S. G., Bateneva A. V., Shishkina L. N., Skarnovich M. O., Medikova L. D., Bogryantseva M. P., Ivanova O. S., Levagina G. M., Danilenko E. D. Interferon-indutsiruyushchaya i protivovirusnaya aktivnost' preparata na osnove analoga interferona-gamma i induktora interferona. [Interferon-inducing and antiviral activity of a drug based on an analogue of interferon-gamma and an interferon inducer]. Meditsinskaya immunologiya = Medical Immunology (Russia). 2017;19(S):266. (In Russ.). URL: https://cyberleninka.ru/article/n/interferon-indutsiruyuschaya-i-protivovirusnayaaktivnost-preparata-na-osnove-analoga-interferona-gamma-i-induktora-interferona

27. Matveev V. A., Shevtsova V. V. Genno-inzhenernyy interferon al'fa-2b dlya mestnogo primeneniya (LAFERONFarmBiotek NAZAL''-NYY) v profilaktike i lechenii ostrykh respiratornykh virusnykh infektsiy. [The topical genetically engineered interferon alfa-2b used in prevention and treatment of acute respiratory viral infections]. Klinicheskaya infektologiya i parazitologiya = Clinical infectology and parasitology. 2013;4(07):136-142. (In Russ.). URL: https://www.elibrary.ru/item.asp?id=20918965

28. Schevruk A. N., Vdovichenko V. P., Bronskaya G. M., Hrebtova O. M., Mahankova T. V. Interferony v sovremennoy farmakoterapii. [Interferons in modern pharmacotherapy]. Vestnik Smolenskoy gosudarstvennoy meditsinskoy akademii = Vestnik of Smolensk State Medical Academy. 2014;13(2):66-75. (In Russ.). URL: https://cyberleninka.ru/article/n/interferony-v-sovremennoy-farmakoterapii

29. Dec M., Puchalski A. Use of oromucosally administered interferon-alpha in the prevention and treatment of animal diseases. Polish journal of veterinary sciences. 2008;11(2):171-182. URL: https://www.researchgate.net/publication/23152509_Use_of_oromucosally_administered_interferona_in_the_prevention_and_treatment_of_animal_diseases

30. Kohara J., Nishikura Y., Konnai S., Tajima M., Onuma M. Effects of interferon-tau on cattle persistently infected

31. with bovine viral diarrhea virus. Jpn. J. Vet. Res. 2012;60(2-3):63-70. URL: https://pubmed.ncbi.nlm.nih.gov/23094581/

32. Glotova T. I., Kungurtseva O. V., Glotov A. G. Deystvie preparatov ekzogennogo interferona na virus virusnoy diarei-bolezni slizistykh krupnogo rogatogo skota. [The drugs exogenous interferon in BVDV]. Agrarnyy vestnik Urala = Agrarian Bulletin of the Urals. 2012;(5(97)):34-36. (In Russ.). URL: https://www.elibrary.ru/item.asp?id=17840245

33. Glotova T. I., Nikonova A. A., Glotov A. G. Protivovirusnye soedineniya i preparaty, effektivnye v otnoshenii virusa virusnoy diarei krupnogo rogatogo skota. [Antiviral compounds and preparations effective against bovine viral diarrhea]. Voprosy virusologii = Problems of Virology. 2017;62(5):204-210. (In Russ.). DOI: https://doi.org/10.18821/0507-4088-2017-62-5-204-210

34. Peek S. F., Bonds M. D., Schaele P., Weber S., Friedrichs K., Schultz R. D. Evaluation of antiviral activity and toxicity of recombinant human interferon alfa-2a in calves persistently infected with type 1 bovine viral diarrhea virus. Am. J. Vet. Res. 2004;65(6):865-870. DOI: https://doi.org/10.2460/ajvr.2004.65.865

35. Iqbal M., Poole E., Goodbourn S., McCauley J. W. Role for bovine viral diarrhea virus Erns glycoprotein in the control of activation of beta interferon by double-stranded RNA.J. Virol. 2004;78(1):136-145. DOI: https://doi.org/10.1128/jvi.78.1.136-145.2004

36. Shan L., Fu F., Xue M., Zhu X., Li L., Feng L., Liu P. Interferon gamma inhibits transmissible gastroenteritis virus infection mediated by an IRF1 signaling pathway. Archives of virology. 2019;164:2659-2669. DOI: https://doi.org/10.1007/s00705-019-04362-2

37. Oksamytny V. M. Іnterferoni: zastosuvannya u veterinarії. [Interferons: application in veterinary medicine]. Bіologіya tvarin = The Animal Biology. 2017;19(3):55-68. (In Ukr.). DOI: https://doi.org/10.15407/animbiol19.03.055

38. Georgiades J. A. Effect of low dose natural human interferon alpha given into the oral cavity on the recovery time and death loss in feedlot hospital pen cattle: a field study. Archivum immunologiae et therapiae experimentalis. 1993;41(3-4):205-207. URL: https://pubmed.ncbi.nlm.nih.gov/8129563/

39. Babiuk L. A., Lawman M. J., Gifford G. A. Use of recombinant bovine alpha 1 interferon in reducing respiratory disease induced by bovine herpesvirus type 1. Antimicrob agents chemother. 1987;31(5):752-757. DOI: https://doi.org/10.1128/aac.31.5.752

40. Peel J. E., Kolly C., Siegenthaler B., Martinod S. R. Prophylactic effects of recombinant bovine interferon-alpha I1 on acute Salmonella typhimurium infection in calves. American journal of veterinary research. 1990;51(7):1095-1099. URL: https://pubmed.ncbi.nlm.nih.gov/2202241/

41. Akiyama K., Sugii S., Hirota Y. A clinical trial of recombinant bovine interferon alpha 1 for the control of bovine respiratory disease in calves. Journal of Veterinary Medical Science. 1993;55(3):449-452. DOI: https://doi.org/10.1292/jvms.55.449

42. Cummins J. M., Hutcheson D. P., Cummins M. J., Georgiades J. A., Richards A. B. Oral therapy with human interferon alpha in calves experimentally injected with infectious bovine rhinotracheitis virus. Archivum immunologiae et therapiae experimentalis. 1993;41(3-4):193-197. URL: https://pubmed.ncbi.nlm.nih.gov/8129561/

43. Kohara J., Nishikura Y., Tajima M., Onuma M., Yokomizo Y. Antiviral effects of bovine IFN-tau and humanIFN-alpha on bovine viral diarrhea virus. Veterinary immunology and immunopathology. 2009;128(1-3):331. DOI: https://doi.org/10.1016/j.vetimm.2008.10.258

44. Bryson D. G., McNulty M. S., Evans R. T., Allan G. Studies of the effect of recombinant human-alpha 1 interferon on experimental parainfluenza type 3 virus infections of the respiratory tract of calves. Veterinary Record. 1989;125(25):615-618. URL: https://pubmed.ncbi.nlm.nih.gov/2559530/

45. Kishko Ia. H., Mukvich M. S. Treatment and prophylaxis of some infectious diseases of swine and cattle using of natural alpha-interferons. Mikrobiologichnii Zhurnal. 1998;60(3):70-79. URL: https://pubmed.ncbi.nlm.nih.gov/9785802/

46. Quintana M. E., Barone L. J., Trotta M. V., Turco C., Mansilla F. C., Capozzo A. V., Cardoso N. P. In-vivo Activity of IFN-λ and IFN-α Against Bovine-Viral-Diarrhea Virus in a Mouse Model. Frontiers in veterinary science. 2020;7:45. DOI: https://doi.org/10.3389/fvets.2020.00045

47. Cummins J. M., Gawthrop J., Hutcheson D. P., Cummins M. J., Zeck D.The effect of low dose oral human interferon alpha therapy on diarrhea in veal calves. Archivum Immunologiae et Therapiae Experimentalis. 1993;41(3-4):199-203. URL: https://www.researchgate.net/publication/15068815_The_effect_of_low_dose_oral_human_interferon_alpha_therapy_on_diarrhea_in_veal_calves

48. Cummins J. M. Interferon administered orally to the bovine species helps treat diseases. Journal of Veterinary Medicine and Research. 2018;5(8):1153. URL: https://www.jscimedcentral.com/VeterinaryMedicine/veterinarymedicine-5-1153.pdf

49. Cummins J. M., Krakowka G. S., Thompson C. G. Systemic effects of interferons after oral administration in animals and humans. American Journal of Veterinary Research. 2006;66(1):164-176. DOI: https://doi.org/10.2460/ajvr.2005.66.164

50. Altynbekov O. M., Andreeva A. V. Vliyanie immunostimulyatorov na nakoplenie spetsificheskikh antitel k vozbuditelyam virusnykh infektsiy v krovi telyat. [The effect of immunostimulants on the accumulation of specific antibodies to viral infection agents in the blood of calves]. Veterinarnyy vrach. 2019;(2):3-8. (In Russ.). DOI: https://doi.org/10.33632/1998-698X.2019-2-3-8

51. Kishko Ia. H., Vasylenko M. I. The use of gamma-interferon for the prevention and treatment of infectious diseases in piglets and calves. Mikrobiologichnii Zhurnal. 1999;61(5):28-32. URL: https://pubmed.ncbi.nlm.nih.gov/10643274/

52. Roth J. M. lmmunomodulation in Bovine Respiratory Disease. The bovine proceedings. 1990;22:150-152. URL: https://journals.tdl.org/bovine/index.php/AABP/article/view/6916/6349

53. Babiuk L. A., Sordillo L. M., Campos M., Hughes H. P., Rossi-Campos A., Harland R. Application of interferons in the control of infectious diseases of cattle. Journal of Dairy Science. 1991;74(12):4385-4398. DOI: https://doi.org/10.3168/jds.S0022-0302(91)78635-9

54. Klimov N. T., Zimnikov V. I., Erin D. A., Pashentsev A. V. Razrabotka optimal'nykh doz bych'ikh rekombinantnykh al'fa i gamma-interferonov dlya profilaktiki mastita u laktiruyushchikh korov. [Development of optimal doses of recombinant bovine alpha and gamma inter feronfor pr evention of mastitis in lactating cows]. Veterinarnyy farmakologicheskiy vestnik = Bulletin of Veterinary Pharmacology. 2018;(3):46-48. (In Russ.). DOI: https://doi.org/10.17238/issn2541-8203.2018.3.46

55. Klimov N. T., Zimnikov V. I., Erin D. A., Pashentsev A. V., Manzhurina O. A., Parkhomenko Yu. S., Chernyshova I. S., Tyurina E. V. Vliyanie bych'ikh rekombinantnykh al'fa i gamma-interferonov na tsitologicheskie i mikrobiologicheskie pokazateli moloka pri subklinicheskom mastite. [The effect of bovine r ecombinant alpha- and gamma-inter ferons on cytological and microbiological char acter isticsof milk with subclinical mastitis]. Veterinarnyy farmakologicheskiy vestnik = Bulletin of Veterinary Pharmacology. 2018;(3):100-103. (In Russ.). DOI: https://doi.org/10.17238/issn2541-8203.2018.3.100

56. Shabunin S. V., Klimov N. T., Vostroilova G. A., Prokulevich V. A., Potapovich M. I., Zimnikov V. I., Erin D. A., Malanych E. V., Pashentsev A. V. Method for the prevention of mastitis in lactating cows: patent Russian Federation no. 2683289, 2019. URL: https://patenton.ru/patent/RU2683289C1.pdf

57. Skorikov V. N. Primenenie bych'ikh rekombinantnykh α-, γ-interferonov i prostaglandina f2α dlya profilaktiki ostrogo posle-rodovogo endometrita u korov. [Combined use of r ecombinant bull α-, γ-inter ferons and prostaglandins f2α for the pr eventionof acute postpartum endometr itis in cows]. Veterinarnyy farmakologicheskiy vestnik = Bulletin of Veterinary Pharmacology. 2019;(2):51-55. (In Russ.). DOI: https://doi.org/10.17238/issn2541-8203.2019.2.51

58. Skorikov V. N., Nezhdanov A. G., Mikhalev V. I., Prokulevich V. A., Potapovich M. I. Bych'i rekombinantnye α i γ-interferony dlya profilaktiki ostrogo poslerodovogo endometrita u korov. [Prevention of acute postpartum endometritis in cows with the use of recombinant bull a-, y-interferons]. Veterinariya = Veterinary. 2019;(11):41-44. (In Russ.). DOI: https://doi.org/10.30896/0042-4846.2019.22.11.41-44

59. Skorikov V. N., Nezhdanov A. G., Mikhalev V. I., Prokulevich V. A., Potapovich M. I. Rekombinantnye α i γ-interferony v mnogokomponentnoy terapii korov pri poslerodovom endometrite. [Recombinant interferons alpha and gamma in multicomponent bovine therapy of postpartum endometritis]. Veterinariya = Veterinary. 2020;(6):10-13. (In Russ.). DOI: https://doi.org/10.30896/0042-4846.2020.23.6.10-13

60. Lecce J. G., Cummins J. M., Richards A. B. Treatment of rotavirus infection in newborn pigs using natural human interferon alpha. Molecular biotherapy. 1990;2(4):211-216. URL: https://pubmed.ncbi.nlm.nih.gov/1963065/

61. Cummins J. M., Mock R. E., Shive B. W., Krakowka S., Richards A. B., Hutcheson D. P. Oral treatment of transmissible gastroenteritis with natural human interferon alpha: a field study. Veterinary Immunology and Immunopathology. 1995;45(3-4):355-360. DOI: https://doi.org/10.1016/0165-2427(94)05351-r

62. Gao D.-M., Yu H.-Y., Zhou W., Xia B.-B., Li H.-Z., Wang M.-L., Zhao J. Inhibitory effects of recombinant porcine interferon-α on porcine transmissible gastroenteritis virus infections in TGEV-seronegative piglets. Veterinary Microbiology. 2021;252:108930. DOI: https://doi.org/10.1016/j.vetmic.2020.108930

63. Amadori M., Razzuoli E. Immune Control of PRRS: Lessons to be Learned and Possible Ways Forward. Frontiers in veterinary science. 2014;1:2. DOI: https://doi.org/10.3389/fvets.2014.00002

64. Gibbert K., Dittmer U. Distinct antiviral activities of IFN-α subtypes. Immunotherapy. 2011;3(7):813-816. DOI: https://doi.org/10.2217/imt.11.74

65. Brockmeier S. L., Loving C. L., Eberle K. C., Hau S. J., Buckley A., Van Geelen A., Montiel N. A., Nicholson T., Lager K. M. Interferon alpha inhibits replication of a live-attenuated porcine reproductive and respiratory syndrome virus vaccine preventing development of an adaptive immune response in swine. Veterinary Microbiology. 2017;212:48-51. DOI: https://doi.org/10.1016/j.vetmic.2017.11.004

66. Liu L., Fan W., Zhang H., Zhang S., Cui L., Wang M., Bai X., Yang W., Sun L., Yang L., Liu W., Li J. Interferon as a Mucosal Adjuvant for an Influenza Vaccine in Pigs. Virologica sinica. 2019;34(3):324-333. DOI: https://doi.org/10.1007/s12250-019-00102-7

67. Yu H. Y., Qu M. S., Zhang J. L., Gan L., Zhao Y., Shan X. Q., Zhou W., Xia B. B., Chen J., Wang M. L., Zhao J. Recombinant Porcine Interferon Alpha Enhances Immune Responses to Killed Porcine Reproductive and Respiratory Syndrome Virus Vaccine in Pigs. Viral Immunology. 2019;32(9):383-392. DOI: https://doi.org/10.1089/vim.2019.0092

68. Kishko Ia. H., Vasylenko M. I. Properties of natural animal gamma-interferons and peculiarities of their action. Mikrobiologichnii Zhurnal. 1998;60(2):65-75. URL: https://pubmed.ncbi.nlm.nih.gov/9670756/

69. Kishko Ia. G., Vasylenko M. I. Action of natural gamma-interferons on functional activity of phagocytes and antibody synthesis after vaccination. Mikrobiologichnii Zhurnal. 2000;62(6):26-32. URL: https://pubmed.ncbi.nlm.nih.gov/11247346/

70. Kishko Ia. H., Vasylenko M. I. The use of gamma-interferon for the prevention and treatment of infectious diseases in piglets and calves. Mikrobiologichnii Zhurnal. 1999;61(5):28-32. URL: https://pubmed.ncbi.nlm.nih.gov/10643274/

71. Vostroilova G. A., Shakhov A. G., Shabunin S. V., Sashnina L. Yu., Parshin P. A., Cheskidova L. V., Kantorovich Yu. A. Korrigiruyushchee vliyanie Gentabiferona-S na immunnyy status porosyat-ot"emyshey i ego effektivnost' pri profilaktike kishechnykh infektsiy. [Corrective influence of Hentabiferon-C on the immune status of post-weaned piglets and its effectiveness in the prevention of intestinal infections]. Rossiyskaya sel'skokhozyaystvennaya nauka. 2018;(6):58-61. (In Russ.). DOI: https://doi.org/10.31857/S250026270001834-2

72. Shakhov A. G., Sashnina L. Yu., Zheynes M. Yu., Vladimirova Yu. Yu., Karmanova N. V. Vliyanie biferona-s na estestvennuyu rezistentnost' i klinicheskiy status porosyat na fone immunomoduliruyushchey profilaktiki poslerodovykh bolezney u svinomatok. [The effect of biferon-c on natural resistance and clinical status of piglets against the background of immunomodulatory prophylaxis of postpartum diseases in sows]. Uchenye zapiski uchrezhdeniya obrazovaniya Vitebskaya ordena Znak pocheta gosudarstvennaya akademiya veterinarnoy meditsiny. 2020;56(4):72-77. (In Belarus). URL: https://www.elibrary.ru/item.asp?id=44367325

73. Shabunin S. V., Shakhov A. G., Vostroilova G. A., Cheskidova L. V., Parshin P. A., Ermakova T. I., Grigoreva N. A. Immunostimuliruyushchiy effekt biferona-S na fone medikamentoznoy profilaktiki bolezney svinomatok i porosyat v promyshlennom svinovodstve. [Porcine biferon-C applied together with medicinal prophylaxis in commercial pig breeding provides immunostimulation of sows and an increased viability of their piglets]. Sel'skokhozyaystvennaya biologiya = Agricultural Biology. 2018;53(4):851-859. (In Russ.). DOI: https://doi.org/10.15389/agrobiology.2018.4.851rus

74. Shakhov A. G., Sashnina L. Yu., Zheynes M. Yu., Vladimirova Yu. Yu., Karmanova N. V. Vliyanie kompleksnogo preparata na osnove interferonov na immunnyy status svinomatok i ego effektivnost' pri profilaktike poslerodovykh bolezney. [The effect of the complex drug based on interferons on the immune status of sows and its efficacy in prevention of postpartum diseases]. Veterinarnyy farmakologicheskiy vestnik = Bulletin of Veterinary Pharmacology. 2020;(2):49-60. (In Russ.). DOI: https://doi.org/10.17238/issn2541-8203.2020.2.49

75. Khmylov A. G., Gavrikov A. V. Miksoferon i Mul'tiferon: metodicheskie rekomendatsii dlya veterinarnykh vrachey. [Mixoferon and Multiferon: guidelines for veterinarians]. Moscow: ZAO «Mosagrogen», 2013. 44 p. URL: https://fermer.ru/files/v2/forum/255858/miksoferonimultiferonmetodicheskierekomendaciidlyavetvrachey.pdf

76. Cheskidova L. V., Briukhova I. V., Grigoreva N. A. Perspektivnye napravleniya sozdaniya lekarstvennykh sredstv novogo pokoleniya dlya zhivotnykh s primeneniem biotekhnologiy (obzor). [Advanced research dir ections of cr eation of new gener ation medicines for animals with application of biotechnologies (review)]. Veterinarnyy farmakologicheskiy vestnik = Bulletin of Veterinary Pharmacology. 2019;(2):29-38. (In Russ.). DOI: https://doi.org/10.17238/issn2541-8203.2019.2.29

77. Shakhov A. G., Sashnina L. Yu., Vladimirova Yu. Yu., Tarakanova K. V., Karmanova N. V. Primenenie tsitokinov i ikh induktorov molodnyaku sel'skokhozyaystvennykh zhivotnykh (obzor). [Cytokines and their inductors using to young farm animals (overview)]. Veterinarnaya patologiya = Veterinary Pathology. 2019;(2):70-79. (In Russ.). URL: https://www.elibrary.ru/item.asp?id=38566762

78. Potapovich M. I., Prokulevich V. A. «Belkovaya veterinariya» kak al'ternativa antibiotikam. Lechebnoprofilakticheskie veterinarnye preparaty na osnove rekombinantnykh belkov. ["Protein veterinary" as alternative to antibiotics. Treatment-and-prophylactic veterinary preparations based on recombinant proteins]. Vestnik BGU. Seriya 2: Khimiya. Biologiya. Geografiya. 2016;(3):68-72. (In Belarus). URL: https://www.elibrary.ru/item.asp?id=29749071

79. Skorokhodkina O. V., Luntsov A. B. Lekarstvennaya allergiya pri provedenii antibiotikoterapii. [Drug allergy in antibiotics using]. Vestnik sovremennoy klinicheskoy meditsiny = The Bulletin of Contemporary Clinical Medicine. 2013;6(3):60-67. (In Russ.). URL: https://www.elibrary.ru/item.asp?id=19118941

80. Molchan N. V., Smirnova Yu. A., Velts N. Yu., Darmostukova M. A., Kazakov A. S., Polivanov V. A. Ftorkhinolonovye antibiotiki: bezopasnost' primeneniya na primere tsiprofloksatsina. [Fluoroquinolone antibiotics: safety of use by the example of ciprofloxacin]. Bezopasnost' i risk farmakoterapii = Safety and Risk of Pharmacotherapy. 2019;7(2):72-83. (In Russ.). DOI: https://doi.org/10.30895/2312-7821-2019-7-2-72-83

81. Kuzmina A. V., Polivanov V. A., Asetskaya I. L., Zyryanov S. K. Voprosy bezopasnosti pri ispol'zovanii antibakterial'nykh preparatov v sovremennoy klinicheskoy praktike. [Safety issues with the use of antimicrobials in current clinical practice]. Klinicheskaya mikrobiologiya i antimikrobnaya khimioterapiya = Clinical Microbiology and Antimicrobial Chemotherapy. 2015;17(2):146-156. (In Russ.). URL: https://cyberleninka.ru/article/n/voprosy-bezopasnosti-priispolzovanii-antibakterialnyh-preparatov-v-sovremennoy-klinicheskoy-praktike

82. Pikuza O. I., Samorodnova E. A. Tenevye storony antibiotikoterapii u detey: o chem dolzhen pomnit' pediatr. [Seamy sides of antibiotic treatment in children: what should a pediatrician remember about]. Prakticheskaya meditsina = Practical medicine. 2018;16(8):50-55. (In Russ.). DOI: https://doi.org/10.32000/2072-1757-2018-8-50-55

83. Belotskiy S. M., Avtalion R. R. Vospalenie. Mobilizatsiya kletok i klinicheskie effekty: monografiya. [Inflammation. Mobilizing of cells and clinical effects: monograph]. Moscow: Izdatel'stvo BIONOM, 2008. 240 p.

84. Dodds D. R. Antibiotic resistance: A current epilogue. Biochem Pharmacol. 2017;134:139-146. DOI: https://doi.org/10.1016/j.bcp.2016.12.005

85. Namazova-Baranova L. S., Baranov A. A. Antibiotikorezistentnost' v sovremennom mire. [Antibiotic Resistance in Modern World]. Pediatricheskaya farmakologiya = Pediatric Pharmacology. 2017;14(5):341-354. (In Russ.). DOI: https://doi.org/10.15690/pf.v14i5.1782

86. McEwen S. A., Collignon P. J. Antimicrobial Resistance: a One Health Perspective. Microbiol Spectr. 2018;6(2). DOI: https://doi.org/10.1128/microbiolspec.ARBA-0009-2017

87. Antonelli G., Currenti M., Turriziani O., Dianzani F. Neutralizing antibodies to interferon-alpha: relative frequency in patients treated with different interferon preparations. The Journal of infectious diseases. 1991;163(4):882-885. DOI: https://doi.org/10.1093/infdis/163.4.882

88. Lin F. C., Young H. A. Interferons: Success in anti-viral immunotherapy. Cytokine Growth Factor Rev. 2014;25(4):369-376. DOI: https://doi.org/10.1016/j.cytogfr.2014.07.015

89. Zeidner N. S., Mathiason-DuBard C. K., Hoover E. A. Reversal of Feline Leukemia Virus Infection by Adoptive Transfer of Lectin/Interleukin-2-Activated Lymphocytes, Interferon-α, and Zidovudine. Journal of Immunotherapy with Emphasis on Tumor Immunology. 1993;14(1):22-32. DOI: https://doi.org/10.1097/00002371-199307000-00004

90. Moore B. R. Clinical application of interferons in large animal medicine. Journal of the American Veterinary Medical Association. 1996;208(10):1711-1715. URL: https://pubmed.ncbi.nlm.nih.gov/8641958/